The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of tumor- and circulating-free DNA methylation to identify clinically relevant small cell lung cancer subtypes.
 
Simon Heeke
Employment - Marker Therapeutics (I)
Honoraria - Qiagen
Consulting or Advisory Role - Boehringer Ingelheim
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - Roche
 
Carl Michael Gay
Honoraria - Aptitude Health; OncLive/MJH Life Sciences; Peerview
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; G1 Therapeutics; Jazz Pharmaceuticals; KisoJi Biotechnology; Monte Rosa Therapeutics; Pharmerit
Speakers' Bureau - AstraZeneca; BeiGene
Research Funding - AstraZeneca
Patents, Royalties, Other Intellectual Property - Patent pending related to small cell lung cancer transcriptional subtypes.
Travel, Accommodations, Expenses - Dava Oncology; ESMO
 
Marcos Roberto Estecio
No Relationships to Disclose
 
Hai T. Tran
No Relationships to Disclose
 
Benjamin B. Morris
No Relationships to Disclose
 
Bingnan Zhang
No Relationships to Disclose
 
XiMing Tang
No Relationships to Disclose
 
Maria G Raso
Research Funding - BD Medical (Inst); Boehringer Ingelheim (Inst); EMD Serono (Inst); Sanofi (Inst)
 
Pedro Rocha
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme
 
Edurne Arriola
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly O.; Merck Sharp & Dohme; Roche; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
Research Funding - AstraZeneca (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Takeda
 
Paul Hofman
Honoraria - Abbvie; Amgen; AstraZeneca; Biocartis; Bristol-Myers Squibb; Guardant Health; Illumina; Janssen; Lilly O.; Merck Sharp & Dohme; Novartis; Pfizer; Pierre Fabre; Roche; Thermo Fisher Scientific
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Biocartis; Bristol-Myers Squibb; Guardant Health; Janssen; Lilly O.; Novartis; Pfizer; Roche
Research Funding - Amgen; AstraZeneca; Biocartis; Bristol-Myers Squibb; Roche; Thermo Fisher Scientific
 
Prasad Kopparapu
No Relationships to Disclose
 
Christine M. Lovly
Honoraria - Amgen; Anheart Therapeutics; Anheart Therapeutics; AstraZeneca; Blueprint Medicines; Cepheid; D2G Oncology; Daiichi Sankyo/Astra Zeneca; EMD Serono; Foundation Medicine; Genentech; InduPro; Janssen Oncology; Lilly; Pfizer; Puma Biotechnology; Syros Pharmaceuticals; Syros Pharmaceuticals; Takeda
Research Funding - AstraZeneca (Inst); Novartis; Xcovery
(OPTIONAL) Uncompensated Relationships - Johnson & Johnson/Janssen; Roche/Genentech
 
Kyle Concannon
No Relationships to Disclose
 
Yuanxin Xi
No Relationships to Disclose
 
Lixia Diao
No Relationships to Disclose
 
Qi Wang
No Relationships to Disclose
 
Jing Wang
No Relationships to Disclose
 
Lauren Averett Byers
Honoraria - Clinical Care Options; UpToDate
Consulting or Advisory Role - Abbvie; Amgen; Arrowhead Pharmaceuticals; AstraZeneca; BeiGene; Chugai Pharma; Daiichi Sankyo; Genentech; Jazz Pharmaceuticals; Merck Sharp & Dohme Corp.; Puma Biotechnology
Research Funding - Amgen (Inst); AstraZeneca (Inst); Jazz Pharmaceuticals (Inst)
 
John Heymach
Consulting or Advisory Role - AstraZeneca; BerGenBio; Boehringer Ingelheim; Bristol-Myers Squibb; DAVA Pharmaceuticals; EMD Serono; Genentech/Roche; GlaxoSmithKline; Hengrui Pharmaceutical; Janssen; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Lilly (Inst); Mirati Therapeutics; Nexus Health Systems; Pneuma Respiratory; Regeneron; Sanofi/Aventis; Spectrum Pharmaceuticals; Takeda
Speakers' Bureau - DAVA Pharmaceuticals; IDEOlogy Health; MJH Life Sciences
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Spectrum Pharmaceuticals; Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Licensing agreement between Spectrum and MD Anderson (including myself) regarding intellectual property for treatment of EGFR and HER2 exon 20 mutations